Lurasidone hydrochloride
Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma, which is also approved for the treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults when used alone or in combination with lithium or valproate.
The related intermediates
4-(1,2-Benzothiazol-3-yl)-1-[(3aR,7aR)-octahydro-2H-isoindol-2-yl ]piperazin-1-ium-1-sulfonate
3-Piperazinobenzisothiazole Hydrochloride
3-(1-Piperazinyl)-1,2-Benzisothiazole
(1R,2R)-Cyclohexane-1,2-diyldimethanol
(1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid
[(1R,2R)-2-(methylsulfonyloxymethyl)cyclohexyl]methyl methanesulfonate
(3aR,4S,7R,7aS)-Hexahydro-4,7-methanoisobenzofuran-1,3-dione
Cis-5-Norbornene-Endo-2,3-Dicarboxylic
5-Norbornene-2,3-Dicarboxylic Anhydride
(3aR,4S,7R,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
For research use only. We do not sell to patients.
Chemical Information
| Name | Lurasidone hydrochloride |
|---|---|
| Iupac Chemical Name | (3aR,4S,7R,7aS)-2-[((1R,2R)-2-{[4-(1,2-benzisothiazol-3-yl)-piperazin-1-yl]methyl}cyclohexyl)methyl]hexahydro-1H-4,7-methanisoindol-1,3-dione |
| Synonyms | Latuda |
| Molecular Formula | C28H37ClN4O2S |
| Molecular Weight | 529.14 |
| Smile | c1ccc2c(c1)c(ns2)N3CCN(CC3)C[C@@H]4CCCC[C@H]4CN5C(=O)[C@@H]6[C@H]7CC[C@H](C7)[C@@H]6C5=O |
| InChiKey | PQXKDMSYBGKCJA-CVTJIBDQSA-N |
| InChi | InChI=1S/C28H36N4O2S/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2/t18-,19+,20-,21-,24+,25-/m0/s1 |
| CAS Number | 367514-87-2 |
| MDL | MFCD14635357 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Chemical Structure
